Challenges with Using the FDA Adverse Event Reporting System to Evaluate the Risk of Benzoyl Peroxide-Containing Products.

HOME
>
論文・技術情報
>
Challenges with Using the FDA Adverse Event Reporting System to Evaluate the Risk of Benzoyl Peroxide-Containing Products.

アブストラクト
ジャーナル名	The Journal of investigative dermatology
Pubmed追加日	2025/5/6
投稿者	Barbieri, John S
組織名	Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts,;USA. Electronic address: jbarbieri@bwh.harvard.edu.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40324588/